MALVERN, Pa., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on developing and commercializing novel gene therapies to address blindness diseases, today announced the appointment of Jolanda Crombach, MSc PharmD, as General…
HUNTSVILLE, Ala., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Octave Intelligence plc (Nasdaq New York: OCTV and Nasdaq Stockholm: OCTV SDB), a global leader in software for the world’s mission critical facilities and infrastructure, will release its third quarter 2026 financial results on Thursday, November…
TORONTO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Xanadu Quantum Technologies Limited (" Xanadu "; NASDAQ/TSX: XNDU), a leading photonic quantum computing company, today announced a strategic multi-year partnership with GlobalFoundries (GF), a leading semiconductor manufacturer, to address the high-volume…
Company Launching Max for All Residential In-Home Trades, a Max Pilot for Commercial and Roofing Customers, Announcing Homh, and Other Key Product Capabilities at Pantheon 2026 Company Launching Max for All Residential In-Home Trades, a Max Pilot for Commercial and Roofing Customers, Announcing…
LONDON and NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced first patients enrolled…
EDMONTON, Alberta, Oct. 06, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (“ SNDL ” or the “ Company ”) announced today that Carlo Cannell has resigned from the Board of Directors effective immediately. The Company thanks Mr. Cannell for his contributions.